Terry Vance - Net Worth and Insider Trading
Terry Vance Net Worth
The estimated net worth of Terry Vance is at least $65,540 dollars as of 2024-09-20. Terry Vance is the Director of Enanta Pharmaceuticals Inc and owns about 5,800 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $65,540. Details can be seen in Terry Vance's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Terry Vance has not made any transactions after 2023-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Terry Vance
Terry Vance Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terry Vance owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Terry Vance’s form 4 insider trades.
Insider Ownership Summary of Terry Vance
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-13 | director |
Terry Vance Latest Holdings Summary
Terry Vance currently owns a total of 1 stock. Terry Vance owns 5,800 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 13, 2023, with a value of $65,540.
Latest Holdings of Terry Vance
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-13 | 5,800 | 11.30 | 65,540 |
Holding Weightings of Terry Vance
Terry Vance Form 4 Trading Tracker
According to the SEC Form 4 filings, Terry Vance has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 15,295 shares on December 13, 2023, which brought Terry Vance around $139,490.
Insider Trading History of Terry Vance
- 1
Terry Vance Trading Performance
GuruFocus tracks the stock performance after each of Terry Vance's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terry Vance is -1.96%. GuruFocus also compares Terry Vance's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terry Vance within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Terry Vance's insider trading performs compared to the benchmark.
Performance of Terry Vance
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.58 | | | | | |
| Relative Return to S&P 500(%) | 10.77 | | | | | |
Terry Vance Ownership Network
Terry Vance Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Terry Vance is the director of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Terry Vance made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 15,295. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 7,230 shares made by Jay R. Luly .
In summary, during the past 3 months, insiders sold 11,945 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 11,945 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Terry Vance Mailing Address
Above is the net worth, insider trading, and ownership report for Terry Vance. You might contact Terry Vance via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
